Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study.
about
Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart AssociationSaliva as a diagnostic tool for oral and systemic diseasesChest pain and high-sensitivity troponin: What is the evidence?Classical and novel biomarkers for cardiovascular risk prediction in the United StatesState of the Art: Newer biomarkers in heart failureTroponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure SectionHigh-sensitivity cardiac troponin-I is elevated in patients with rheumatoid arthritis, independent of cardiovascular risk factors and inflammationEffect of antioxidant supplementation on exercise-induced cardiac troponin release in cyclists: a randomized trialGDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in menCoronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohortsHeart disease and stroke statistics--2014 update: a report from the American Heart AssociationHeart disease and stroke statistics--2012 update: a report from the American Heart AssociationThe Role of Emerging Risk Factors in Cardiovascular OutcomesHeart Disease and Stroke Statistics-2017 Update: A Report From the American Heart AssociationEpidemiology of cardiovascular disease: recent novel outlooks on risk factors and clinical approaches.Point-of-care diagnostics for niche applications.High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities study.Prevalence of heart failure signs and symptoms in a large primary care population identified through the use of text and data mining of the electronic health record.Troponin T, NT-proBNP, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).Predictive value of high-sensitivity troponin-I for future adverse cardiovascular outcome in stable patients with type 2 diabetes mellitus.Association of heart-type fatty acid-binding protein with cardiovascular risk factors and all-cause mortality in the general population: the Takahata study.Arterial Velocity Pulse Index as a Novel Marker of Atherosclerosis Using Pulse Wave Analysis on High Sensitivity Troponin T in Hypertensive PatientsClinical criteria replenish high-sensitive troponin and inflammatory markers in the stratification of patients with suspected acute coronary syndrome.High-sensitivity cardiac troponin T is a biomarker for atherosclerosis in systemic lupus erythematous patients: a cross-sectional controlled study.Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk.N-terminal pro-brain natriuretic peptide and associated factors in the general working population: a baseline survey of the Uranosaki cohort study.Gene expression analyses of mouse aortic endothelium in response to atherogenic stimuliBiomarkers and cardiovascular risk assessment for primary prevention: an update.Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study.Association of glomerular filtration rate with high-sensitivity cardiac troponin T in a community-based population study in BeijingThird universal definition of myocardial infarction.Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage.Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study.Serum microRNAs profile from genome-wide serves as a fingerprint for diagnosis of acute myocardial infarction and angina pectoris.High-sensitivity troponin T and cardiovascular events in systolic blood pressure categories: atherosclerosis risk in communities study.B-type natriuretic peptides improve cardiovascular disease risk prediction in a cohort of womenUse of a highly-sensitive cardiac troponin I assay in a screening population for hypertrophic cardiomyopathy: a case-referent studyBiomarkers of cardiovascular disease risk in women.Clinical implications of high-sensitivity cardiac troponin measurements in hospitalized medical patientsNT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
P2860
Q22306356-D0EE2112-1AF5-43D6-9B3F-FABE5BFB7D72Q26764819-866DF115-9460-42EC-ADAB-F622CD7BEFA1Q26771814-788AED16-E08E-4468-8559-008773F064A1Q26824026-F8D2539A-08F0-4434-B44C-B9C2CE7893C5Q27027899-6AA78AC5-6B35-421A-82B6-84B4C383828CQ28269814-C42F1756-FF61-480C-8F6E-5EB488D9FB6DQ28480869-A8190003-9CE1-49A6-8850-AB9DC10ABF0DQ28535273-48EA1C84-1D9B-42D0-B9BA-FDFDAC22A241Q28535575-055CDF46-170E-4052-8D3B-F0389E8E6B82Q28686330-4CF07D43-5110-4F86-9475-F44940CE20ACQ29547691-4E0C0CF2-42B2-4A65-B0A3-9AB911DF3385Q29547909-8682BA76-F103-4632-A600-A56BDCFBD0D6Q30234550-4525F7AA-A38A-440D-9D31-E1FD2E4C62F2Q30238784-3F8491F3-9952-4CE8-B20B-08CE2449E48BQ30251632-2BE6FDBD-1574-428A-8F58-CCCDFC27B8BCQ30357499-00F88151-F770-4DFE-AC90-5BF68F5B01EBQ30583705-B73A41B0-E1B3-4326-AC32-F6B0D449EF31Q30795407-133A30F7-BB1D-4E87-B9D6-E3EAAC2CA470Q33551467-C2CDE3CB-EA7D-412C-B103-A43762C4D641Q33552596-BF17EC20-0E18-4680-BBD9-17BB2BD15CC2Q33644456-F5951501-C4DE-4563-96F3-689DD8644E9FQ33647468-1429B10D-A036-4185-A473-83EEAFC30BFBQ33706806-AA3F2BE7-A8F1-41FC-B5ED-350FEBD75CC1Q33795895-2A8BA5A9-2257-4E3F-89BB-73E6E42261DBQ33873812-A31DF243-B3A1-4D24-A7B7-9DD8915EFDD9Q33918896-1AC8848C-CF77-4804-A1E8-886BE4D7BD49Q33927042-88189EC9-A11F-412D-B079-4CB48301AD8FQ33927398-36D47E53-7881-423B-86AB-731933691093Q34231061-A429C4E8-D1E1-4563-9650-658C7952F58AQ34295470-7002CBAC-F95D-482B-8954-9869EEDBABDBQ34295914-03B111A0-D943-48C0-B5EE-7082B7C9EC06Q34345083-6800DD39-F38C-4495-ACCD-16E67730255AQ34397304-2D1C2AD1-01A9-49B4-AF69-9710F9EDE90DQ34704614-93003398-A042-4294-935A-05BD02CC5917Q34718054-96907620-6F5A-4855-ACC1-92AA4FEC87A0Q34954819-9F0CA9A9-1595-4D5E-914F-CDD83DDFE7ACQ34983078-664D12C8-DDB1-43EA-AB87-C1A25A2D6E09Q35025720-7EBF9BD9-FB77-49A1-8989-C56636040459Q35031757-4D62E5CC-8356-4FC5-B494-241627D2D65DQ35051193-A1F901A4-42A1-477F-BE3A-55608EDEB158
P2860
Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cardiac troponin T measured by ...... sis Risk in Communities Study.
@ast
Cardiac troponin T measured by ...... sis Risk in Communities Study.
@en
Cardiac troponin T measured by ...... sis Risk in Communities Study.
@nl
type
label
Cardiac troponin T measured by ...... sis Risk in Communities Study.
@ast
Cardiac troponin T measured by ...... sis Risk in Communities Study.
@en
Cardiac troponin T measured by ...... sis Risk in Communities Study.
@nl
prefLabel
Cardiac troponin T measured by ...... sis Risk in Communities Study.
@ast
Cardiac troponin T measured by ...... sis Risk in Communities Study.
@en
Cardiac troponin T measured by ...... sis Risk in Communities Study.
@nl
P2093
P2860
P50
P1433
P1476
Cardiac troponin T measured by ...... sis Risk in Communities Study.
@en
P2093
Brad C Astor
Christie M Ballantyne
James A de Lemos
Justin T Saunders
Lloyd E Chambless
Ron C Hoogeveen
Salim S Virani
Vijay Nambi
Xiaoxi Liu
P2860
P304
P356
10.1161/CIRCULATIONAHA.110.005264
P407
P577
2011-03-21T00:00:00Z